During Monday’s current trade, KeyCorp (NYSE:KEY)’s shares dropped -0.49%, and is now trading at $14.18, as Pacific Crest Securities, a partner of KeyCorp. releases Top Tech Industry insights from 2015 emerging Technology Summit today.
Pacific Crest Securities, held its 10th Emerging Technology Summit in San Francisco on March 3-4. The investment bank hosted more than 1,100 participants at the conference, counting executives from more than 250 public and private technology companies and 500 investment professionals from industry-leading venture capital, private equity, mutual and hedge funds.
Pacific Crest’s team captured insights from technology thought leaders and reports the following emerging trends will transform the competitive landscape for several tech sectors, counting Security & Data Analytics, SaaS, Cloud Infrastructure and Consumer, Internet & Digital, through the next several years.
- Private companies in Security Software & Data Analytics will continue to experience triple-digit growth due to high-profile breaches and the willingness from enterprises to invest in security infrastructure.
- The SaaS space will experience a continued infrastructure shift from software-defined to developer-defined.
- CIOs are increasingly willing to move mission-critical applications to the cloud.
- New e-commerce companies are avoiding Amazon and finding unique ways to partner with traditional retailers to create compelling experiences and gain customers.
KeyCorp operates as the bank holding corporation for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States.
Gilead Sciences Inc. (NASDAQ:GILD)’s shares declined -0.27% during the current trading session Monday, and is now trading at $98.16, as Gilead Sciences, formerly on March 26, declared the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Sovaldi® (sofosbuvir), a once-daily nucleotide analog polymerase inhibitor, for the suppression of viremia in patients with genotype 2 chronic hepatitis C virus (HCV) infection with or without compensated cirrhosis. Sovaldi is indicated for use in combination with ribavirin (RBV) for 12 weeks. Sovaldi (in combination with RBV) is the first all-oral, interferon-free treatment regimen for genotype 2 HCV infection. Sovaldi is also the first product to be marketed by Gilead in Japan.
Primarily due to HCV, Japan has one of the highest rates of liver cancer of any industrialized country. Of the more than one million people chronically infected with HCV, 20-30 percent have the genotype 2 strain of the virus. Presently approved therapies in Japan for genotype 2 HCV infection involve 24-48 weeks of injections with pegylated interferon, which may not be suitable for many patients.
Sovaldi’s approval is supported by data from a Phase 3 clinical trial conducted in Japan (Study GS-US-334-0118) among treatment-naïve and treatment-practiced genotype 2 patients. Approval was based on 96 percent (n=135/140) of genotype 2 HCV-infected patients who received 12 weeks of an all-oral regimen of Sovaldi plus RBV 600–1,000 mg/day achieving a sustained virologic response 12 weeks after concluding therapy (SVR12). Patients who achieve SVR12 are considered cured of HCV infection. The approval is also supported by SVR12 results from four international Phase 3 studies (FISSION, FUSION, POSITRON and VALENCE), which comprised of genotype 2 HCV patients.
Gilead Sciences, Inc., a biopharmaceutical corporation, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. The corporations products comprise Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver disease.
During current trade, Groupon, Inc. (NASDAQ:GRPN)’s shares climbed 0.50%, and is now trading at $7.09, as Groupon, on last Wednesday, declared the debut of Grøüber (www.groupon.com/grouber)––a revolutionary new car service with feline drivers that provides people with affordable transportation to their Groupon deals. Grøüber uses cars with GPS-guided red lasers that signal the correct route to the four-legged captain behind the wheel. In addition, Grøüber riders save more than just a whisker of cash through fares that only decrease when demand surges.
“We’ve yet to see anyone successfully tackle the transportation-for-hire market, and launching our own service made purrfect sense for Groupon because we have tens of millions of customers looking to redeem deals without having to claw their way through traffic,” said Barnicus Stapleton, feline fleet commander and director of haulage and wellness, Groupon. “With Grøüber, we make redeeming a Groupon even more seamless by having our cats physically deliver customers to the business. And best of all, you can be assured of a peaceful ride because everyone knows that cats have complete indifference towards people.”
Groupon, Inc. operates online local commerce marketplaces that connect merchants to consumers by offering goods and services at a discount worldwide. It also offers deals on products for which it acts as the merchant of record.
Goldcorp Inc. (NYSE:GG), during its Monday’s current trading session gained 2.81%, and is now trading at $19.38, as Goldcorp, declared today that it has reached a binding letter of intent whereby it will sell its 40% interest in the South Arturo Mine Project located in Nevada to Premier Gold Mines Ltd. (PG.TO). The South Arturo Mine Project is a joint venture between Goldcorp, a 40% owner, and Barrick, a 60% owner and the operator of the Project.
Under the Contract, Goldcorp will receive consideration of $20 million in cash at closing and a further 5% interest in the Rahill-Bonanza Joint Venture in Red Lake, subject to Barrick not exercising its right of first refusal in respect of the Project and completion of definitive documentation. Concurrent with the divestiture, Goldcorp has agreed to complete a private placement with Premier in the amount of C$12.5 million, subject to Toronto Stock Exchange approval.
The closing of the attainment, which is subject to Barrick not exercising its right of first refusal in respect of the Project and completion of definitive documentation, is predictable to occur by the end of May 2015.
Goldcorp Inc. engages in the attainment, exploration, development, and operation of gold properties in Canada, the United States, and Latin America. The corporation primarily explores for gold, silver, copper, lead, and zinc deposits.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
